Search Results

Serotonin 5-HT3 and 5-HT4 Ligands: An Update of Medicinal Chemistry Research in the Last Few Years

Authors: Modica, M. N.; Pittala, V.; Romeo, G.; Salerno, L.; Siracusa, M. A.

Source: Current Medicinal Chemistry, Volume 17, Number 4, February 2010 , pp. 334-362(29)

Publisher: Bentham Science Publishers

Pharmacological Treatment of Fibromyalgia Syndrome: New Developments

Author: Staud, Roland

Source: Drugs, Volume 70, Number 1, 1 January 2010 , pp. 1-14(14)

Publisher: Adis International

Eletriptan

Authors: Sandrini, Giorgio; Perrotta, Armando; Tassorelli, Cristina; Nappi, Giuseppe

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 12, December 2009 , pp. 1587-1598(12)

Publisher: Informa Healthcare

Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for `sick fat' and metabolic disease

Author: Bays, Harold E

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 11, November 2009 , pp. 1429-1445(17)

Publisher: Expert Reviews

Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty

Authors: Verheij, Michel; Veenvliet, Jesse; Groot Kormelink, Tom; Steenhof, Maaike; Cools, Alexander

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 441-455(15)

Publisher: Springer

The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression (Supplementary Tables)

Authors: Ruf, B. M.; Bhagwagar, Z.

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1118-1138(21)

Publisher: Bentham Science Publishers

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting

Authors: Guidotti, Mario; Ravasio, Roberto

Source: Clinical Drug Investigation, Volume 29, Number 11, 1 November 2009 , pp. 693-702(10)

Publisher: Adis International

Chemical Interactions with Pyramidal Neurons in Layer 5 of the Cerebral Cortex: Control of Pain and Anxiety

Author: Adams Jr., J. D.

Source: Current Medicinal Chemistry, Volume 16, Number 27, September 2009 , pp. 3476-3479(4)

Publisher: Bentham Science Publishers

Cannabinoid receptor 1 signalling dampens activity and mitochondrial transport in networks of enteric neurones

Authors: boesmans, w.; ameloot, k.; van den abbeel, v.; tack, j.; vanden berghe, p.

Source: Neurogastroenterology and Motility, Volume 21, Number 9, September 2009 , pp. 958-e77(-957)

Publisher: Blackwell Publishing

The Use of Tripeptides for Lead Discovery of 5-HT4 Receptor Ligands

Authors: Hanna-Elias, A.; Thompson, P. E.; Manallack, D. T.; Irving, H. R.; Coupar, I. M.; Berque-Bestel, I.; Iskander, M. N.

Source: Protein and Peptide Letters, Volume 16, Number 7, July 2009 , pp. 805-809(5)

Publisher: Bentham Science Publishers

Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT_1A receptor agonist

Authors: Newman-Tancredi, A; Martel, J-C; Assié, M-B; Buritova, J; Lauressergues, E; Cosi, C; Heusler, P; Bruins Slot, L; Colpaert, FC; Vacher, B; Cussac, D

Source: British Journal of Pharmacology, Volume 156, Number 2, January 2009 , pp. 338-353(16)

Publisher: Blackwell Publishing

Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models

Authors: Rodriguez Bambico, Francis; Duranti, Andrea; Tontini, Andrea; Tarzia, Giorgio; Gobbi, Gabriella

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1623-1646(24)

Publisher: Bentham Science Publishers

Pathological laughing and crying may be caused by many neurological disorders and is highly responsive to treatment

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 4, April 2009 , pp. 18-20(3)

Publisher: Adis International

Recovery of Locomotor Function with Combinatory Drug Treatments Designed to Synergistically Activate Specific Neuronal Networks

Author: Guertin, Pierre A.

Source: Current Medicinal Chemistry, Volume 16, Number 11, April 2009 , pp. 1366-1371(6)

Publisher: Bentham Science Publishers

Agonist-Trafficking and Hallucinogens

Authors: Gonzalez-Maeso, Javier; Sealfon, Stuart C.

Source: Current Medicinal Chemistry, Volume 16, Number 8, March 2009 , pp. 1017-1027(11)

Publisher: Bentham Science Publishers

Atypical Neuroleptic Malignant Syndrome or Serotonin Toxicity Associated with Atypical Antipsychotics?

Author: Odagaki, Yuji

Source: Current Drug Safety, Volume 4, Number 1, January 2009 , pp. 84-93(10)

Publisher: Bentham Science Publishers

Individual Triptan Selection in Migraine Attack Therapy

Authors: Belvis, Robert; Pagonabarraga, Javier; Kulisevsky, Jaime

Source: Recent Patents on CNS Drug Discovery, Volume 4, Number 1, January 2009 , pp. 70-81(12)

Publisher: Bentham Science Publishers

Combined 5-HT_1A and 5-HT_1B receptor agonists for the treatment of l-DOPA-induced dyskinesia

Authors: Muñoz, Ana; Li, Qin; Gardoni, Fabrizio; Marcello, Elena; Qin, Chuan; Carlsson, Thomas; Kirik, Deniz; Di Luca, Monica; Björklund, Anders; Bezard, Erwan; Carta, Manolo

Source: Brain, Volume 131, Number 12, 26 December 2008 , pp. 3380-3394(15)

Publisher: Oxford University Press

Antidepressants for the Treatment of Insomnia: A Suitable Approach?

Author: Wiegand, Michael H.

Source: Drugs, Volume 68, Number 17, 2008 , pp. 2411-2417(7)

Publisher: Adis International

DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease

Authors: Heptinstall, Stan; Espinosa, David Iyu; Manolopoulos, Panagiotis; Glenn, Jackie; White, Ann; Johnson, Andrew; Dovlatova, Natalia; Fox, Sue; May, Jane; Hermann, David; Magnusson, Olafur; Stefansson, Kari; Hartman, Dan; Gurney, Mark

Source: Platelets, Volume 19, Number 8, December 2008 , pp. 605-613(9)

Publisher: Informa Healthcare